Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 152 articles:
HTML format
Text format



Single Articles


    May 2017
  1. LIU CH, Liu CJ, Hong CM, Su TH, et al
    A noninvasive diagnosis of hepatic fibrosis by BioFibroScore(R) in chronic hepatitis C patients.
    J Gastroenterol Hepatol. 2017 May 26. doi: 10.1111/jgh.13834.
    PubMed     Text format     Abstract available


  2. SVIKLANE L, Olmane E, Dzerve Z, Kupcs K, et al
    Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes.
    J Gastroenterol Hepatol. 2017 May 2. doi: 10.1111/jgh.13814.
    PubMed     Text format     Abstract available


  3. KIM JH, Lim KS, Min YW, Lee H, et al
    Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    J Gastroenterol Hepatol. 2017;32:1064-1070.
    PubMed     Text format     Abstract available


  4. MAIA L, Ferreira JM, Pedroto I
    Hepatobiliary and Pancreatic: Unusual cause of acute pancreatitis.
    J Gastroenterol Hepatol. 2017;32:948.
    PubMed     Text format    


    April 2017
  5. ITO K, Murotani K, Nakade Y, Inoue T, et al
    Serum WFA+ -M2BP levels predict liver fibrosis, development of hepatocellular carcinoma, and overall survival: A meta-analysis.
    J Gastroenterol Hepatol. 2017 Apr 12. doi: 10.1111/jgh.13802.
    PubMed     Text format     Abstract available


  6. BASIR DN, Telisinghe PU, Bickle I, Chong VH, et al
    Hepatobiliary and Pancreatic: Malignant rhabdoid tumor of the liver.
    J Gastroenterol Hepatol. 2017;32:738.
    PubMed     Text format    


  7. LOURENCO LC, Horta DV, Reis J
    Hepatobiliary and Pancreatic: Gastric outlet obstruction from pancreatitis-induced intramural duodenal haematoma.
    J Gastroenterol Hepatol. 2017;32:739.
    PubMed     Text format    


    March 2017
  8. JIANG T, Du F, Qin N, Lu Q, et al
    Systematical analyses of variants in DNase I hypersensitive sites identified two novel hepatocellular carcinoma susceptibility loci among Chinese population.
    J Gastroenterol Hepatol. 2017 Mar 20. doi: 10.1111/jgh.13790.
    PubMed     Text format     Abstract available


  9. KUO YH, Wang JH, Hung CH, Rau KM, et al
    The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib.
    J Gastroenterol Hepatol. 2017 Mar 11. doi: 10.1111/jgh.13783.
    PubMed     Text format     Abstract available


  10. HSIEH YC, Lee KC, Chen PH, Su CW, et al
    Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding.
    J Gastroenterol Hepatol. 2017 Mar 8. doi: 10.1111/jgh.13777.
    PubMed     Text format     Abstract available


  11. SATO M, Tateishi R, Yasunaga H, Matsui H, et al
    Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: a nationwide survey.
    J Gastroenterol Hepatol. 2017 Mar 7. doi: 10.1111/jgh.13780.
    PubMed     Text format     Abstract available


  12. MIYATA T, Yamashita Y, Yamao T, Umezaki N, et al
    Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma.
    J Gastroenterol Hepatol. 2017;32:547.
    PubMed     Text format    


  13. HWANG HE, Tseng HS, Liu CA, Chiou YY, et al
    Hepatobiliary and Pancreatic: Obstructive jaundice after transarterial chemoembolization of hepatocellular carcinoma related to intraductal tumor necrotic fragment.
    J Gastroenterol Hepatol. 2017;32:546.
    PubMed     Text format    


    February 2017
  14. KIRSTEIN MM, Schweitzer N, Winter T, Lappas K, et al
    Patterns and challenges of treatment sequencing in patients with hepatocellular carcinoma -experience from a referral center.
    J Gastroenterol Hepatol. 2017 Feb 10. doi: 10.1111/jgh.13761.
    PubMed     Text format     Abstract available


  15. LYON KC, Likar E, Martello JL, Regier M, et al
    Retrospective Cross-Sectional Pilot Study of Rifaximin Dosing for the Prevention of Recurrent Hepatic Encephalopathy.
    J Gastroenterol Hepatol. 2017 Feb 8. doi: 10.1111/jgh.13759.
    PubMed     Text format     Abstract available


  16. SAWAHARA H, Shiraha H, Uchida D, Kato H, et al
    Promising therapeutic efficacy of a novel REIC/Dkk-3 expressing adenoviral vector for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Feb 6. doi: 10.1111/jgh.13757.
    PubMed     Text format     Abstract available


  17. YOOPRASERT S, Thanapirom K, Treeprasertsuk S, Kullavanijaya P, et al
    Hepatobiliary and Pancreatic: Epstein-Barr virus-associated smooth muscle tumors: Unusual cause of hepatic mass in AIDS patient.
    J Gastroenterol Hepatol. 2017;32:293.
    PubMed     Text format    


  18. CHUNG SM, Kim KH, Kim KO, Kim TN, et al
    Hepatobiliary and Pancreatic: Hepatic portal vein gas accompanied by acute enterocolitis improved with non-surgical treatment.
    J Gastroenterol Hepatol. 2017;32:294.
    PubMed     Text format    


  19. ROBERTSON M, Watanabe M
    JGH OPEN: A new open access journal for gastroenterology and hepatology.
    J Gastroenterol Hepatol. 2017;32:289.
    PubMed     Text format    


    January 2017
  20. SEKI A, Ikeda F, Miyatake H, Takaguchi K, et al
    Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.
    J Gastroenterol Hepatol. 2017 Jan 23. doi: 10.1111/jgh.13746.
    PubMed     Text format     Abstract available


  21. ZHOU D, Pan Q, Liu XL, Yang RX, et al
    Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation.
    J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13742.
    PubMed     Text format     Abstract available


  22. XUE R, Feng J, Meng Q, Lv F, et al
    The Significance of Glypican-3 Expression Profiling in the Tumor Cellular Origin Theoretical System for Hepatocellular Carcinoma Progression.
    J Gastroenterol Hepatol. 2017 Jan 14. doi: 10.1111/jgh.13736.
    PubMed     Text format     Abstract available


  23. LEE SJ, Kim SU, Kim MD, Kim YH, et al
    Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
    J Gastroenterol Hepatol. 2017 Jan 13. doi: 10.1111/jgh.13729.
    PubMed     Text format     Abstract available


  24. SI T, Chen Y, Ma D, Gong X, et al
    Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: a meta-analysis.
    J Gastroenterol Hepatol. 2017 Jan 13. doi: 10.1111/jgh.13727.
    PubMed     Text format     Abstract available


  25. WANG Y, Huang W, Li R, Yun Z, et al
    Systematic Quantitation of Histologic Patterns Shows Accuracy in Reflecting Cirrhotic Remodeling.
    J Gastroenterol Hepatol. 2017 Jan 9. doi: 10.1111/jgh.13722.
    PubMed     Text format     Abstract available


  26. REY S, Quintavalle C, Burmeister K, Calabrese D, et al
    LIVER DAMAGE AND SENESCENCE INCREASES IN PATIENTS DEVELOPING HEPATOCELLULAR CARCINOMA.
    J Gastroenterol Hepatol. 2017 Jan 3. doi: 10.1111/jgh.13717.
    PubMed     Text format     Abstract available


  27. BHAMIDIMARRI KR, Lanza DC, Kashikar ND
    Hepatobiliary and Pancreatic: A unique case of HPV related metastatic Schneiderian carcinoma presenting as polycystic liver disease.
    J Gastroenterol Hepatol. 2017;32:10.
    PubMed     Text format    


  28. SANO I, Kuwatani M, Sugiura R, Kato S, et al
    Hepatobiliary and Pancreatic: A rare case of a well-differentiated neuroendocrine tumor in the bile duct with spontaneous regression diagnosed by EUS-FNA.
    J Gastroenterol Hepatol. 2017;32:11.
    PubMed     Text format    


    December 2016
  29. BEKKI Y, Yoshizumi T, Shimoda S, Itoh S, et al
    Hepatic stellate cells secrete WFA+ -M2BP; its role in biological interactions with Kupffer cells.
    J Gastroenterol Hepatol. 2016 Dec 22. doi: 10.1111/jgh.13708.
    PubMed     Text format     Abstract available


  30. WANG C, Li G, Li J, Li J, et al
    Overexpression of the metastasis-associated gene MTA3 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Dec 19. doi: 10.1111/jgh.13680.
    PubMed     Text format     Abstract available


  31. ZHAO Q, Zhang GL, Zhu X, Su D, et al
    The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients.
    J Gastroenterol Hepatol. 2016 Dec 16. doi: 10.1111/jgh.13678.
    PubMed     Text format     Abstract available


  32. HUANG TS, Lin CL, Shyu YC, Yeh CT, et al
    Diabetes, hepatocellular carcinoma, and mortality in hepatitis C-infected patients: a population-based cohort study.
    J Gastroenterol Hepatol. 2016 Dec 8. doi: 10.1111/jgh.13670.
    PubMed     Text format     Abstract available


  33. RANA SS, Sharma R, Sharma V, Dhalaria L, et al
    Hepatobiliary and Pancreatic: Unusual space occupying lesion of liver.
    J Gastroenterol Hepatol. 2016;31:1916.
    PubMed     Text format    


  34. CHETCUTI ZAMMIT S, Chircop A, Cortis K, Pullicino E, et al
    Hepatobiliary and Pancreatic: Congenital intrahepatic portosystemic venous shunting: A great mimicker of liver cirrhosis.
    J Gastroenterol Hepatol. 2016;31:1917.
    PubMed     Text format    


    November 2016
  35. SHARMA BC, Singh J, Srivastava S, Sangam A, et al
    A Randomized Controlled Trial Comparing Lactulose Plus Albumin versus Lactulose alone for Treatment of Hepatic Encephalopathy.
    J Gastroenterol Hepatol. 2016 Nov 25. doi: 10.1111/jgh.13666.
    PubMed     Text format     Abstract available


  36. PARK JH, Lee DH, Park MS, Jung YS, et al
    CCR5 deficiency exacerbates alcoholic fatty liver disease through pro-inflammatory cytokines and chemokines-induced hepatic inflammation.
    J Gastroenterol Hepatol. 2016 Nov 17. doi: 10.1111/jgh.13657.
    PubMed     Text format     Abstract available


  37. KIM JH, Sinn DH, Gwak GY, Kang W, et al
    Insulin resistance assessment is useful in risk stratification of hepatocellular carcinoma in chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2016 Nov 11. doi: 10.1111/jgh.13647.
    PubMed     Text format     Abstract available


  38. LEE YR, Park SY, Kim SU, Jang SY, et al
    Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.
    J Gastroenterol Hepatol. 2016 Nov 10. doi: 10.1111/jgh.13644.
    PubMed     Text format     Abstract available


  39. BUSK TM, Moller S, Pedersen EB, Gerbes A, et al
    Aquaporin-2 Excretion in Hospitalized Patients with Cirrhosis: Relation to Development of Renal Insufficiency and Mortality.
    J Gastroenterol Hepatol. 2016 Nov 7. doi: 10.1111/jgh.13641.
    PubMed     Text format     Abstract available


  40. SUN H, Song J, Weng C, Xu J, et al
    Decreased expression of the macrophage scavenger receptor MARCO is associated with tumour progression and poor prognosis in human hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Nov 2. doi: 10.1111/jgh.13633.
    PubMed     Text format     Abstract available


  41. HU HJ, Jing QY, Cheng NS, Li FY, et al
    Hepatobiliary and Pancreatic: A hepatic mass involving diaphragm: A real malignancy?
    J Gastroenterol Hepatol. 2016;31:1801.
    PubMed     Text format    


    October 2016
  42. LEE EC, Kim SH, Park H, Lee SD, et al
    Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Consecutive Cohort of 1002 Patients.
    J Gastroenterol Hepatol. 2016 Oct 31. doi: 10.1111/jgh.13632.
    PubMed     Text format     Abstract available


  43. INOUE M, Ogasawara S, Chiba T, Ooka Y, et al
    Presence of non-hypervascular hypointense nodules on Gd-EOB-DTPA enhanced MRI in patients with hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Oct 27. doi: 10.1111/jgh.13622.
    PubMed     Text format     Abstract available


  44. WARNE CD, Zaloumis SG, Bertalli NA, Delatycki MB, et al
    HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: a genotype-stratified cohort study of hemochromatosis in Australian women.
    J Gastroenterol Hepatol. 2016 Oct 26. doi: 10.1111/jgh.13621.
    PubMed     Text format     Abstract available


  45. AHN JM, Kim CH, Um SH, Kim KM, et al
    A validation Study Associating Glutaminase Promoter Variations with Hepatic Encephalopathy in East Asian Populations.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13618.
    PubMed     Text format     Abstract available



  46. Hepatology Clinical.
    J Gastroenterol Hepatol. 2016;31 Suppl 2:89-120.
    PubMed     Text format    


    September 2016
  47. ZHAO H, Chen C, Gu S, Yan X, et al
    Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
    J Gastroenterol Hepatol. 2016 Sep 26. doi: 10.1111/jgh.13603.
    PubMed     Text format     Abstract available


  48. LIU P, Qiu Y, Qian Y, Chen X, et al
    Quality of Meta-analyses in Major Leading Gastroenterology and Hepatology Journals: A Systematic Review.
    J Gastroenterol Hepatol. 2016 Sep 6. doi: 10.1111/jgh.13591.
    PubMed     Text format     Abstract available


  49. NOUSO K, Kariyama K, Nakamura S, Oonishi A, et al
    Application of Radiofrequency Ablation for the Treatment of Intermediate-Stage Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2016 Sep 6. doi: 10.1111/jgh.13586.
    PubMed     Text format     Abstract available


    August 2016
  50. CHAN AW, Wong GL, Chan HY, Tong JH, et al
    Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.
    J Gastroenterol Hepatol. 2016 Aug 22. doi: 10.1111/jgh.13536.
    PubMed     Text format     Abstract available


  51. CHOI SI, Yu A, Kim BH, Ko EJ, et al
    A Model Predicting Survival of Patients with Recurrent or Progressive Hepatocellular Carcinoma: The MORE Score.
    J Gastroenterol Hepatol. 2016 Aug 12. doi: 10.1111/jgh.13532.
    PubMed     Text format     Abstract available


  52. HU HT, Yao QJ, Meng YL, Li HL, et al
    Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: long-term outcome analysis.
    J Gastroenterol Hepatol. 2016 Aug 12. doi: 10.1111/jgh.13529.
    PubMed     Text format     Abstract available


  53. MORIO K, Imamura M, Kawakami Y, Morio R, et al
    Real-World Efficacy and Safety of Daclatasvir and Asunaprevir Therapy for Hepatitis C Virus-Infected Cirrhosis Patients.
    J Gastroenterol Hepatol. 2016 Aug 11. doi: 10.1111/jgh.13511.
    PubMed     Text format     Abstract available


  54. LEE YK, Jung KS, Kim DY, Choi JY, et al
    Tumor size might not distinguish outcomes between conventional and drug-eluting chemoembolization for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Aug 9. doi: 10.1111/jgh.13501.
    PubMed     Text format     Abstract available


    July 2016
  55. RUDNICKA A, Woziwodzka A, Wroblewska A, Rybicka M, et al
    Analysis of polymorphism and hepatic expression of duodenal cytochrome b in chronic hepatitis C.
    J Gastroenterol Hepatol. 2016 Jul 20. doi: 10.1111/jgh.13495.
    PubMed     Text format     Abstract available


  56. HURRY PK, Poulsen JH, Bendtsen F, Moller S, et al
    Neutrophil gelatinase associated lipocalin and Cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction.
    J Gastroenterol Hepatol. 2016 Jul 20. doi: 10.1111/jgh.13492.
    PubMed     Text format     Abstract available


  57. LEBRETON A, Sinegre T, Pereira B, Lamblin G, et al
    Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.
    J Gastroenterol Hepatol. 2016 Jul 15. doi: 10.1111/jgh.13493.
    PubMed     Text format     Abstract available


    June 2016
  58. LIANG XE, Zhong C, Huang L, Yang S, et al
    Stepwise Application of Transient Elastography and Routine Biomarkers Optimizes Hepatitis B Cirrhosis Detection.
    J Gastroenterol Hepatol. 2016 Jun 26. doi: 10.1111/jgh.13475.
    PubMed     Text format     Abstract available


  59. CHAN AW, Chong CC, Mo FK, Wong J, et al
    Incorporating Albumin-Bilirubin grade into the Cancer of the Liver Italian Program system for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Jun 2. doi: 10.1111/jgh.13457.
    PubMed     Text format     Abstract available


    May 2016
  60. TSAI WL, Yeh PH, Tsai CY, Ting CT, et al
    Efficient Programming of Human Mesenchymal Stem Cell Derived Hepatocytes by Epigenetic Regulations.
    J Gastroenterol Hepatol. 2016 May 24. doi: 10.1111/jgh.13451.
    PubMed     Text format     Abstract available


  61. NOVEIRY BB, Hirbod-Mobarakeh A, Khalili N, Hourshad N, et al
    Specific immunotherapy in Hepatocellular cancer: a Systematic Review.
    J Gastroenterol Hepatol. 2016 May 21. doi: 10.1111/jgh.13449.
    PubMed     Text format     Abstract available


  62. KIM SS, Nam JS, Cho HJ, Won JH, et al
    Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 May 18. doi: 10.1111/jgh.13448.
    PubMed     Text format     Abstract available


  63. CHOLONGITAS E, Ioannidou M, Goulis I, Chalevas P, et al
    Comparison of Creatinine and Cystatin Formulae with 51 Chromium-Edta Glomerular Filtration Rate in Patients With Decompensated Cirrhosis.
    J Gastroenterol Hepatol. 2016 May 13. doi: 10.1111/jgh.13446.
    PubMed     Text format     Abstract available


  64. PATERNOSTRO R, Reiberger T, Mandorfer M, Schwarzer R, et al
    Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
    J Gastroenterol Hepatol. 2016 May 10. doi: 10.1111/jgh.13439.
    PubMed     Text format     Abstract available


  65. PHAN VA, Abu-Assi R, Nguyen N
    Utility of per-oral cholangioscopy in the diagnosis of portal hypertension associated biliopathy.
    J Gastroenterol Hepatol. 2016 May 10. doi: 10.1111/jgh.13442.
    PubMed     Text format    


  66. LIU J, Wang J, Jin D, Qi C, et al
    Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic HBV.
    J Gastroenterol Hepatol. 2016 May 9. doi: 10.1111/jgh.13436.
    PubMed     Text format     Abstract available


  67. KUTTING F, Schubert J, Franklin J, Bowe A, et al
    Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis.
    J Gastroenterol Hepatol. 2016 May 3. doi: 10.1111/jgh.13421.
    PubMed     Text format     Abstract available


  68. LAI YC, Wu P, Huang CC, Wu CH, et al
    Intra-hepatic arterio-biliary fistula complicated by blunt abdomen trauma demonstrated at angiogram.
    J Gastroenterol Hepatol. 2016 May 1. doi: 10.1111/jgh.13433.
    PubMed     Text format    


  69. LUANGSUKRERKA T, Aumpansuba P, Chaiteerakija R
    Liver abscesso-colonic fistula: A rare complication of transarterial chemoembolization for treatment of hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 May 1. doi: 10.1111/jgh.13431.
    PubMed     Text format    


    April 2016
  70. XU X, Li B, Zheng C
    Acute acalculous cholecystitis in systemic lupus erythematosus.
    J Gastroenterol Hepatol. 2016 Apr 30. doi: 10.1111/jgh.13430.
    PubMed     Text format    


  71. K YADAV S, Goel A, A Saraswat V, A Thomas M, et al
    Evaluation of Cognitivity, Proinflammatory Cytokines, and Brain MRI in Minimal Hepatic Encephalopathy induced by Cirrhosis and EHPVO.
    J Gastroenterol Hepatol. 2016 Apr 27. doi: 10.1111/jgh.13427.
    PubMed     Text format     Abstract available


  72. ZHANG P, Yang Y, Wen F, Wheeler J, et al
    Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.
    J Gastroenterol Hepatol. 2016 Apr 27. doi: 10.1111/jgh.13425.
    PubMed     Text format     Abstract available


  73. CHIEN J, Liu J, Lee MH, Jen CL, et al
    Risk and Predictors of Hepatocellular Carcinoma for Chronic Hepatitis b Patients With Newly Developed Cirrhosis.
    J Gastroenterol Hepatol. 2016 Apr 26. doi: 10.1111/jgh.13422.
    PubMed     Text format     Abstract available


  74. TARDELLI M, Moreno-Viedma V, Zeyda M, Itariu BK, et al
    Adiponectin regulates aquaglyceroporin expression in hepatic stellate cells altering their functional state.
    J Gastroenterol Hepatol. 2016 Apr 15. doi: 10.1111/jgh.13415.
    PubMed     Text format     Abstract available


  75. SHEPTULINA A, Shirokova E, Nekrasova T, Blum H, et al
    Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    J Gastroenterol Hepatol. 2016 Apr 5. doi: 10.1111/jgh.13407.
    PubMed     Text format     Abstract available


  76. GUO B, Li D
    A hepatic space-occupying lesion in a woman of childbearing age.
    J Gastroenterol Hepatol. 2016 Apr 4. doi: 10.1111/jgh.13396.
    PubMed     Text format     Abstract available


  77. KUROKAWA T, Zheng YW, Ohkohchi N
    Novel functions of platelets in the liver.
    J Gastroenterol Hepatol. 2016;31:745-51.
    PubMed     Text format     Abstract available


  78. TSENG CM, Chuang HW, Tai CM
    EDUCATION AND IMAGING. Gastrointestinal: Duodenal metastatic epithelioid angiosarcoma.
    J Gastroenterol Hepatol. 2016;31:705.
    PubMed     Text format    


  79. DE LEDINGHEN V, Wong GL, Vergniol J, Chan HL, et al
    Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2016;31:848-55.
    PubMed     Text format     Abstract available


  80. DONG Y, Wang WP, Mao F, Ji ZB, et al
    Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.
    J Gastroenterol Hepatol. 2016;31:822-8.
    PubMed     Text format     Abstract available


    March 2016
  81. WU W, Zhang J, Yang W, Hu B, et al
    The role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome.
    J Gastroenterol Hepatol. 2016 Mar 31. doi: 10.1111/jgh.13388.
    PubMed     Text format     Abstract available


  82. CHAN WK, Wong VW
    Oxidized low-density lipoprotein in non-alcoholic steatohepatitis.
    J Gastroenterol Hepatol. 2016 Mar 25. doi: 10.1111/jgh.13381.
    PubMed     Text format    


  83. KAO JH, Tung SY, Lee Y, Thongsawat S, et al
    Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.
    J Gastroenterol Hepatol. 2016 Mar 19. doi: 10.1111/jgh.13374.
    PubMed     Text format     Abstract available


  84. MAAN R, Zaim R, van der Meer AJ, Feld JJ, et al
    Real-world medical costs of antiviral therapy among patients with chronic HCV infection and advanced hepatic fibrosis.
    J Gastroenterol Hepatol. 2016 Mar 18. doi: 10.1111/jgh.13373.
    PubMed     Text format     Abstract available


  85. CHAN AW, Chong CC, Mo FK, Wong J, et al
    Applicability of Albumin-Bilirubin-based Japan Integrated Staging (ALBI-T) score in hepatitis B-associated hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Mar 15. doi: 10.1111/jgh.13339.
    PubMed     Text format     Abstract available


  86. KIM JW, Seong J, Park MS, Kim KS, et al
    Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery.
    J Gastroenterol Hepatol. 2016 Mar 10. doi: 10.1111/jgh.13334.
    PubMed     Text format     Abstract available


  87. HU Y, Zhang H, Li J, Cong X, et al
    Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.
    J Gastroenterol Hepatol. 2016;31:676-84.
    PubMed     Text format     Abstract available


  88. SINCLAIR M, Grossmann M, Angus PW, Hoermann R, et al
    Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease.
    J Gastroenterol Hepatol. 2016;31:661-7.
    PubMed     Text format     Abstract available


  89. HEEBOLL S, El-Houri RB, Hellberg YE, Haldrup D, et al
    Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.
    J Gastroenterol Hepatol. 2016;31:668-75.
    PubMed     Text format     Abstract available


    February 2016
  90. JIN YJ, Lee SH, Cho SG, Kim JH, et al
    Prediction of Postoperative Liver Failure using Gadoxetic Acid-enhanced Magnetic Resonance Imaging in Patients with Hepatocellular Carcinoma.
    J Gastroenterol Hepatol. 2016 Feb 24. doi: 10.1111/jgh.13327.
    PubMed     Text format     Abstract available


  91. KAIDA T, Higashi T, Kitano Y, Yamamura K, et al
    Degenerative hepatic hemangioma mimicking biliary cystadenocarcinoma.
    J Gastroenterol Hepatol. 2016 Feb 20. doi: 10.1111/jgh.13325.
    PubMed     Text format    


  92. FRIEDRICH K, Smit M, Wannhoff A, Rupp C, et al
    Coffee consumption protects against progression in liver cirrhosis and increases long-term survival after liver transplantation.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13319.
    PubMed     Text format     Abstract available


  93. LIU H, Liu J, Zhang Y, Liao J, et al
    Contrast-enhanced ultrasound and CT perfusion imaging of a liver fibrosis-early cirrhosis in dogs.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13320.
    PubMed     Text format     Abstract available


  94. NISHIDA N, Yada N, Hagiwara S, Sakurai T, et al
    Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13318.
    PubMed     Text format     Abstract available


  95. ZHANG AY, Lai CL, Poon RT, Huang FY, et al
    Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Feb 15. doi: 10.1111/jgh.13316.
    PubMed     Text format     Abstract available


  96. PELUCCHI S, Galimberti S, Greni F, Rametta R, et al
    Proprotein convertase 7 rs236918 is associated with liver fibrosis in Italian patients with HFE-related Hemochromatosis.
    J Gastroenterol Hepatol. 2016 Feb 11. doi: 10.1111/jgh.13315.
    PubMed     Text format     Abstract available


  97. SHAO YY, Liu TH, Lee YH, Hsu CH, et al
    Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Feb 9. doi: 10.1111/jgh.13312.
    PubMed     Text format     Abstract available


  98. HALABI SA, Sawas T, Sadat B, Jandali A, et al
    Early TIPS Versus Endoscopic Therapy for Secondary Prophylaxis After Management of Acute Esophageal Variceal Bleeding in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials.
    J Gastroenterol Hepatol. 2016 Feb 9. doi: 10.1111/jgh.13303.
    PubMed     Text format     Abstract available


  99. LU C, Wang K, Zhang CZ, Zhou FG, et al
    The outcomes of intrahepatic cholangiocarcinoma with portal vein tumor thrombus following hepatic resection.
    J Gastroenterol Hepatol. 2016 Feb 8. doi: 10.1111/jgh.13309.
    PubMed     Text format     Abstract available


  100. KIM HY, Chang Y, Park JY, Ahn H, et al
    Characterization of acute-on-chronic liver failure and prediction of mortality in Asian patients with active alcoholism.
    J Gastroenterol Hepatol. 2016;31:427-33.
    PubMed     Text format     Abstract available


  101. CHEN RX, Gan YH, Ge NL, Chen Y, et al
    Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    J Gastroenterol Hepatol. 2016;31:442-9.
    PubMed     Text format     Abstract available


  102. SASAKI H, Murakami Y, Uemura K, Hashimoto Y, et al
    EDUCATION AND IMAGING. Hepatobiliary and Pancreatic: Long-term survival of serous cystadenocarcinoma of the pancreas with synchronous liver metastases after aggressive surgical resection.
    J Gastroenterol Hepatol. 2016;31:287.
    PubMed     Text format    


    January 2016
  103. SATO S, Genda T, Ichida T, Murata A, et al
    Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Jan 13. doi: 10.1111/jgh.13295.
    PubMed     Text format     Abstract available


  104. CHAN AW, Kumada T, Toyoda H, Tada T, et al
    Integration of albumin-bilirubin (ALBI) score into Barcelona clinic liver cancer (BCLC) system for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2016 Jan 9. doi: 10.1111/jgh.13291.
    PubMed     Text format     Abstract available


  105. CHUA TC, Roseverne LO, Goh AC, Maher R, et al
    Hepatobiliary and Pancreatic: Dual system stenting of the biliary and porto-venous systems to palliate locoregional recurrence of hilar cholangiocarcinoma.
    J Gastroenterol Hepatol. 2016 Jan 5. doi: 10.1111/jgh.13285.
    PubMed     Text format    


  106. EL SEBAY HM, Safan MA, Daoud AA, Tayel SI, et al
    Association of factor V Leiden, Janus kinase 2, prothrombin, and MTHFR mutations with primary Budd-Chiari syndrome in Egyptian patients.
    J Gastroenterol Hepatol. 2016;31:235-40.
    PubMed     Text format     Abstract available


  107. KAPIL S, Duseja A, Sharma BK, Singla B, et al
    Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2016;31:213-21.
    PubMed     Text format     Abstract available


  108. CHEN JP, Peng B, Tang L, Sun R, et al
    Fetal and infant exposure to the Chinese famine increases the risk of fatty liver disease in Chongqing, China.
    J Gastroenterol Hepatol. 2016;31:200-5.
    PubMed     Text format     Abstract available


  109. CARBONE LJ, Angus PW, Yeomans ND
    Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2016;31:23-31.
    PubMed     Text format     Abstract available


  110. DING PX, Zhang SJ, Li Z, Fu MT, et al
    Long-term safety and outcome of percutaneous transhepatic venous balloon angioplasty for Budd-Chiari syndrome.
    J Gastroenterol Hepatol. 2016;31:222-8.
    PubMed     Text format     Abstract available


    December 2015
  111. SINGH J, Sharma BC, Maharshi S, Puri V, et al
    Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    J Gastroenterol Hepatol. 2015 Dec 30. doi: 10.1111/jgh.13283.
    PubMed     Text format     Abstract available


  112. CHEN J, Fan X, Zhou L, Gao X, et al
    Treatment with geraniol ameliorates methionine-choline deficient diet-induced nonalcoholic steatohepatitis in rats.
    J Gastroenterol Hepatol. 2015 Dec 22. doi: 10.1111/jgh.13272.
    PubMed     Text format     Abstract available


  113. EATON JE, Dzyubak B, Venkatesh SK, Smyrk TC, et al
    Performance of magnetic resonance elastography in primary sclerosing cholangitis.
    J Gastroenterol Hepatol. 2015 Dec 21. doi: 10.1111/jgh.13263.
    PubMed     Text format     Abstract available


  114. FUNG AC, Chok KS, Lo AW, Lo CM, et al
    Hepatic splenosis - a rare differential in an HBV endemic area.
    J Gastroenterol Hepatol. 2015 Dec 20. doi: 10.1111/jgh.13275.
    PubMed     Text format    


  115. VAN DER MEER AJ, Maan R, Veldt BJ, Feld JJ, et al
    Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13252.
    PubMed     Text format     Abstract available


  116. HIRAOKA A, Kumada T, Michitaka K, Toyoda H, et al
    Usefulness of albumin-bilirubin (ALBI) grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13250.
    PubMed     Text format     Abstract available


  117. QIN B, Wei T, Wang L, Ma N, et al
    Decreased expression of TIPE2 contributes to the hyper-reactivity of monocyte to TLR ligands in primary biliary cirrhosis.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13251.
    PubMed     Text format     Abstract available


  118. GAETANO JN, Micic D, Aronsohn A, Reddy G, et al
    The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.
    J Gastroenterol Hepatol. 2015 Dec 8. doi: 10.1111/jgh.13255.
    PubMed     Text format     Abstract available


  119. WANG YB, Zhang JY, Gong JP, Zhang F, et al
    Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: A meta-analysis.
    J Gastroenterol Hepatol. 2015 Dec 5. doi: 10.1111/jgh.13248.
    PubMed     Text format     Abstract available


  120. DAITOKU N, Okabe H, Hashimoto D, Chikamoto A, et al
    Hepatobiliary and Pancreatic: Replaced common hepatic artery on left gastric artery: a rare anomaly and implication for pancreaticoduodenectomy.
    J Gastroenterol Hepatol. 2015;30:1695.
    PubMed     Text format    


  121. NEPAL P, Kumar D, Ramanathan S, Faki A, et al
    Hepatobiliary and Pancreatic: Gall bladder duplication presenting with gall-stone pancreatitis: Use of hepatobiliary specific MRCP in preoperative evaluation of ductal anatomy.
    J Gastroenterol Hepatol. 2015;30:1694.
    PubMed     Text format    


    November 2015
  122. LAI WJ, Chiu NC, Chau GY
    Hepatobiliary and pancreatic: Unusual enhancing tumor in hepatitis B carrier.
    J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13237.
    PubMed     Text format    


  123. GASSIEP I, Clark PJ, McManus DP, Looke DL, et al
    Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic schistosoma mansoni infection and post- praziquantel therapy.
    J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13239.
    PubMed     Text format    


  124. MAIWALL R, Kumar S, Sharma MK, Wani Z, et al
    Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis.
    J Gastroenterol Hepatol. 2015 Nov 24. doi: 10.1111/jgh.13243.
    PubMed     Text format     Abstract available


  125. ADAMS LA, Arauz O, Angus PW, Sinclair M, et al
    The additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
    J Gastroenterol Hepatol. 2015 Nov 21. doi: 10.1111/jgh.13240.
    PubMed     Text format     Abstract available


  126. GOH GB, Issa D, Lopez R, Dasarathy S, et al
    The development of a non-invasive model to predict the presence of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2015 Nov 20. doi: 10.1111/jgh.13235.
    PubMed     Text format     Abstract available


  127. NAGAOKI Y, Aikata H, Nakano N, Shinohara F, et al
    Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.
    J Gastroenterol Hepatol. 2015 Nov 19. doi: 10.1111/jgh.13236.
    PubMed     Text format     Abstract available


  128. POK S, Barn VA, Wong HJ, Blackburn AC, et al
    Testosterone regulation of cyclin E kinase is a key factor determining gender differences in hepatocarcinogenesis.
    J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13232.
    PubMed     Text format     Abstract available


  129. HIRAMATSU N, Yamada R, Takehara T
    The suppressive effect of nucleos(t)ide analogue treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.
    J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13229.
    PubMed     Text format     Abstract available


  130. KIM Y, Lee EJ, Jang HK, Kim CH, et al
    Statin pretreatment inhibits the LPS-induced EMT via the downregulation of TLR4 and NF-kappaB in human biliary epithelial cells.
    J Gastroenterol Hepatol. 2015 Nov 17. doi: 10.1111/jgh.13230.
    PubMed     Text format     Abstract available


    October 2015
  131. WANG D, Wang Q, Yin J, Dong R, et al
    Combined administration of propranolol plus AG490 offers better effects on portal hypertensive rats with cirrhosis.
    J Gastroenterol Hepatol. 2015 Oct 21. doi: 10.1111/jgh.13207.
    PubMed     Text format     Abstract available


    June 2015
  132. TOMENO W, Kawashima K, Yoneda M, Saito S, et al
    Non-alcoholic fatty liver disease comorbid with major depressive disorder: The pathological features and poor therapeutic efficacy.
    J Gastroenterol Hepatol. 2015;30:1009-14.
    PubMed     Text format     Abstract available


  133. LIM S, Han J, Kim GM, Han KH, et al
    Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib.
    J Gastroenterol Hepatol. 2015;30:1024-31.
    PubMed     Text format     Abstract available


  134. SEKIMOTO T, Maruyama H, Kondo T, Shimada T, et al
    Potential stagnation in the splanchnic hemodynamics demonstrated by the dynamic microbubbles in chronic liver disease.
    J Gastroenterol Hepatol. 2015;30:1001-8.
    PubMed     Text format     Abstract available


    May 2015
  135. ZHANG L, You W, Zhang H, Peng R, et al
    PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.
    J Gastroenterol Hepatol. 2015;30:821-9.
    PubMed     Text format     Abstract available


  136. KIMURA T, Deshpande GA, Urayama KY, Masuda K, et al
    Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
    J Gastroenterol Hepatol. 2015;30:909-17.
    PubMed     Text format     Abstract available


  137. KARRAR A, Stepanova M, Alaparthi L, Lingam S, et al
    Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2015;30:900-8.
    PubMed     Text format     Abstract available


  138. YANG X, Miao R, Yang H, Chi T, et al
    Retrospective and comparative study of inflammatory myofibroblastic tumor of the liver.
    J Gastroenterol Hepatol. 2015;30:885-90.
    PubMed     Text format     Abstract available


    April 2015
  139. CHENG R, Cooper A, Kench J, Watson G, et al
    Ipilimumab-induced toxicities and the gastroenterologist.
    J Gastroenterol Hepatol. 2015;30:657-66.
    PubMed     Text format     Abstract available


  140. YE LC, Wei Y, Zhu DX, Chen T, et al
    Impact of early tumor shrinkage on clinical outcome in wild-type-KRAS colorectal liver metastases treated with cetuximab.
    J Gastroenterol Hepatol. 2015;30:674-9.
    PubMed     Text format     Abstract available


  141. JIA J, Hou J, Ding H, Chen G, et al
    Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B.
    J Gastroenterol Hepatol. 2015;30:756-62.
    PubMed     Text format     Abstract available


  142. CHOUDHARY NS, Saraf N, Saigal S, Gautam D, et al
    Estimation of normal values of serum transaminases based on liver histology in healthy Asian Indians.
    J Gastroenterol Hepatol. 2015;30:763-6.
    PubMed     Text format     Abstract available


  143. SHIN JY, Kim MJ, Kim ES, Mo EY, et al
    Association between serum calcium and phosphorus concentrations with non-alcoholic fatty liver disease in Korean population.
    J Gastroenterol Hepatol. 2015;30:733-41.
    PubMed     Text format     Abstract available


    February 2015
  144. CHANG ML, Hsu CM, Tseng JH, Tsou YK, et al
    Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders.
    J Gastroenterol Hepatol. 2015;30:329-36.
    PubMed     Text format     Abstract available


  145. GAO L, Ge C, Fang T, Zhao F, et al
    ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2015;30:396-404.
    PubMed     Text format     Abstract available


  146. SONG CY, Zeng X, Wang Y, Shi J, et al
    Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis.
    J Gastroenterol Hepatol. 2015;30:405-12.
    PubMed     Text format     Abstract available


  147. WANG JH, Kee KM, Lin CY, Hung CH, et al
    Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2015;30:358-63.
    PubMed     Text format     Abstract available


  148. SINCLAIR M, Grossmann M, Gow PJ, Angus PW, et al
    Testosterone in men with advanced liver disease: abnormalities and implications.
    J Gastroenterol Hepatol. 2015;30:244-51.
    PubMed     Text format     Abstract available


  149. LIN ZY, Wu CC, Chuang YH, Chuang WL, et al
    Clinical utility of a simple primary culture method in hepatocellular carcinoma patients.
    J Gastroenterol Hepatol. 2015;30:352-7.
    PubMed     Text format     Abstract available


    January 2015
  150. DONG R, Zheng S
    Interleukin-8: A critical chemokine in biliary atresia.
    J Gastroenterol Hepatol. 2015 Jan 22. doi: 10.1111/jgh.12900.
    PubMed     Text format     Abstract available


    August 2014
  151. KASHIHARA H, Shimada M, Kurita N, Sato H, et al
    Duodenal-jejunal bypass improves diabetes and liver steatosis via enhanced glucagon-like peptide-1 elicited by bile acids.
    J Gastroenterol Hepatol. 2014 Aug 4. doi: 10.1111/jgh.12690.
    PubMed     Text format     Abstract available


  152. OGASAWARA S, Akiba J, Nakayama M, Nakashima O, et al
    Epithelial cell adhesion molecule-positive human hepatic neoplastic cells can develop combined hepatocellular-cholangiocarcinoma in mice.
    J Gastroenterol Hepatol. 2014 Aug 4. doi: 10.1111/jgh.12692.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: